Efficacy and safety of the addition of a dipeptidyl peptidase-4 inhibitor to insulin therapy in patients with type 2 diabetes: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

Efficacy and safety of the addition of a dipeptidyl peptidase-4 inhibitor to insulin therapy in patients with type 2 diabetes: A systematic review and meta-analysis

Published:2016-06 Issue: Volume:116 Page:86-95
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

Kim Yeong Gi,Min Se Hee,Hahn Seokyung,Oh Tae Jung,Park Kyong Soo,Cho Young Min

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference37 articles.

1. Global estimates of diabetes prevalence in adults for 2013 and projections for 2035;Guariguata;Diabetes Res Clin Pract,2014

2. Banting lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus;Defronzo;Diabetes,2009

3. Five stages of evolving beta-cell dysfunction during progression to diabetes;Weir;Diabetes,2004

4. Standards of medical care in diabetes-2014;American Diabetes;Diabetes Care,2014

5. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD);Inzucchi;Diabetes Care,2012

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of GLP‐1 Receptor Agonists, SGLT‐2 Inhibitors, and DPP‐4 Inhibitors as an Add‐On Drug to Insulin Combined With Oral Hypoglycemic Drugs: Umbrella Review;Journal of Diabetes Research;2024-01

2. The role of Recent Pharmacotherapeutic Options on the Management of Treatment Resistant Type 2 Diabetes;Expert Opinion on Pharmacotherapy;2022-06-28

3. Metabolic Dysfunction in the Regulation of the NLRP3 Inflammasome Activation: A Potential Target for Diabetic Nephropathy;Journal of Diabetes Research;2022-06-09

4. Emerging Roles of Dipeptidyl Peptidase-4 Inhibitors in Delaying the Progression of Type 1 Diabetes Mellitus;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;2021-02

5. Dipeptidyl Peptidase-4 Inhibitors;Stroke Revisited;2021